Catalyst Pharmaceuticals
CPRX
#3628
Rank
โ‚น368.84 B
Marketcap
โ‚น3,014
Share price
-0.02%
Change (1 day)
43.33%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2025 (TTM): โ‚น24.79 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.58 Billion. , an increase over its 2024 earnings that were of โ‚น20.87 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น27.36 B31.1%
2024 โ‚น20.87 B128.82%
2023 โ‚น9.12 B-9.75%
2022 โ‚น10.10 B98.83%
2021 โ‚น5.08 B
2019 โ‚น3.22 B-198.25%
2018 -โ‚น3.29 Billion84.68%
2017 -โ‚น1.78 Billion1.88%
2016 -โ‚น1.75 Billion-10.68%
2015 -โ‚น1.96 Billion30.46%
2014 -โ‚น1.5 Billion27.6%
2013 -โ‚น1.18 Billion198.17%
2012 -โ‚น0.4 Billion-36.22%
2011 -โ‚น0.62 Billion59.52%
2010 -โ‚น0.39 Billion-44.68%
2009 -โ‚น0.7 Billion-31.45%
2008 -โ‚น1.02 Billion155.21%
2007 -โ‚น0.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.507 T 9,063.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.022 T 3,635.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น785.39 B 2,770.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น67.79 Billion-347.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-โ‚น26.24 Billion-195.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น37.21 B 36.00%๐Ÿ‡บ๐Ÿ‡ธ USA